Applied Dna Sciences (APDN)

Company Profile

we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.

Company profile

Ticker

APDN, APPDW

Exchange

NASDAQ

Website

www.adnas.com/

CEO

James Hayward

Incorporated

Delaware

Location

New York

Fiscal year end

Sep 30

Sector

Manufacturing > Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing

Industry (SIC)

Services - Testing Laboratories

Neogenomics • Digipath • 20/20 GeneSystems • UL Solutions ...

Former names

DATALINK CAPITAL CORP/TX/, DCC ACQUISITION CORP, PROHEALTH MEDICAL TECHNOLOGIES INC

SEC CIK

0000744452

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

APDN (B.V.I.) Inc. • Applied DNA Sciences Europe Limited • Applied DNA Sciences India Private Limited • LineaRX, Inc. • Applied DNA Clinical Labs LLC • Spindle Biotech, Inc. ...

IRS number

592262718

APDN stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

8-K

Applied DNA Announces Fourth Quarter Fiscal Year 2023

7 Dec 23

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

6 Dec 23

8-K

Entry into a Material Definitive Agreement

7 Nov 23

424B5

Prospectus supplement for primary offering

7 Nov 23

8-K

Submission of Matters to a Vote of Security Holders

20 Sep 23

8-K

Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update

10 Aug 23

Additional proxy soliciting materials

7 Aug 23

DEF 14A

Definitive proxy

7 Aug 23

Transcripts

View all

APDN

Earnings call transcript

2023 Q4

7 Dec 23

APDN

Earnings call transcript

2023 Q3

10 Aug 23

APDN

Earnings call transcript

2023 Q2

12 May 23

APDN

Earnings call transcript

2023 Q1

9 Feb 23

APDN

Earnings call transcript

2022 Q4

17 Dec 22

APDN

Earnings call transcript

2022 Q3

11 Aug 22

APDN

Earnings call transcript

2022 Q2

14 May 22

APDN

Earnings call transcript

2022 Q1

10 Feb 22

APDN

Earnings call transcript

2021 Q4

10 Dec 21

APDN

Earnings call transcript

2021 Q3

13 Aug 21

Latest ownership filings

View all

AWM Investment Company, Inc.

Financial summary

Financial statements Chart APDN financial data

Quarter (USD)	Sep 23	Jun 23	Mar 23	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Sep 23	Sep 22	Sep 21	Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	7.90 mm	7.90 mm	7.90 mm	7.90 mm	7.90 mm	7.90 mm
Cash burn (monthly)	1.20 mm	609.46 k	1.39 mm	1.15 mm	893.26 k	518.14 k
Cash used (since last report)	2.77 mm	1.41 mm	3.21 mm	2.66 mm	2.06 mm	1.19 mm
Cash remaining	5.13 mm	6.50 mm	4.70 mm	5.24 mm	5.84 mm	6.71 mm
Runway (months of cash)	4.3	10.7	3.4	4.5	6.5	12.9

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2023

APDN institutional ownership history Ownership history

20.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	31	29	+6.9%
Opened positions	5	3	+66.7%
Closed positions	3	4	-25.0%
Increased positions	6	2	+200.0%
Reduced positions	4	7	-42.9%

13F shares	Current	Prev Q	Change
Total value	3.20 bn	3.04 bn	+5.4%
Total shares	2.79 mm	2.51 mm	+10.8%
Total puts	9.10 k	8.90 k	+2.2%
Total calls	91.80 k	87.00 k	+5.5%
Total put/call ratio	0.1	0.1	-3.1%

Largest owners	Shares	Value	Change
AWM Investment	808.81 k	$994.83 mm	-0.1%
AMH Equity	587.23 k	$710.55 mm	+76.3%
Vanguard	523.69 k	$633.67 mm	+3.4%
Susquehanna International	140.19 k	$172.44 mm	+17.1%
Hirschman Orin	140.00 k	$620.00 k	0.0%
Geode Capital Management	139.19 k	$171.26 mm	+7.6%
BLK Blackrock	101.66 k	$123.01 mm	0.0%
Atria Wealth Solutions	81.01 k	$98.02 mm	-0.2%
STT State Street	75.68 k	$93.08 mm	0.0%
Raymond James & Associates	49.88 k	$60.35 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
AMH Equity	587.23 k	+254.23 k	+76.3%
Cowen Prime Advisors	0.00	-98.30 k	EXIT
Sabby Management	38.90 k	+38.90 k	NEW
Susquehanna International	140.19 k	+20.42 k	+17.1%
Vanguard	523.69 k	+17.24 k	+3.4%
HM Payson & Co	15.40 k	+15.40 k	NEW
Two Sigma Securities	12.82 k	+12.82 k	NEW
Geode Capital Management	139.19 k	+9.83 k	+7.6%
Provence Wealth Management	2.00 k	+2.00 k	NEW
AWM Investment	808.81 k	-1.00 k	-0.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

APDN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
23 Mar 23	Jantzen Beth	Common Stock	Grant	Acquire A	No	No	0	91,667	0.00	91,739
23 Mar 23	Jantzen Beth	NQSO Common Stock	Grant	Acquire A	No	No	1.08	1,961	2.12 k	1,961
23 Mar 23	Jantzen Beth	Incentive Stock Option Common Stock	Grant	Acquire A	No	No	1.08	98,039	105.88 k	98,039
23 Mar 23	Clay Shorrock	Common Stock	Grant	Acquire A	No	No	0	91,667	0.00	91,667
23 Mar 23	Clay Shorrock	NQSO Common Stock	Grant	Acquire A	No	No	1.08	1,961	2.12 k	1,961
23 Mar 23	Clay Shorrock	Incentive Stock Option Common Stock	Grant	Acquire A	No	No	1.08	98,039	105.88 k	98,039
23 Mar 23	Murrah Judith	Common Stock	Grant	Acquire A	No	No	0	99,306	0.00	101,853
23 Mar 23	Murrah Judith	NQSO Common Stock	Grant	Acquire A	No	No	1.08	10,294	11.12 k	10,294
23 Mar 23	Murrah Judith	Incentive Stock Option Common Stock	Grant	Acquire A	No	No	1.08	98,039	105.88 k	98,039
25 Jan 23	Catell Robert B	NQSO Common Stock	Grant	Acquire A	No	No	1.41	39,428	55.59 k	39,428